Neonatal Acquisition of ESBL-PE in a Low-income Country - NeoLIC

NCT ID: NCT04836208

Last Updated: 2022-10-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-30

Study Completion Date

2023-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Enterobacteriaceae, more specifically Escherichia coli and Klebsiella pneumoniae, are the bacteria most often responsible for neonatal infections in low-income countries. Infections caused by multidrug-resistant Enterobacteriaceae: Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E), are more often associated with an unfavorable outcome of the infection.

Enterobacteriaceae colonize the digestive tract which is the first step in developing a potential infection. Very few studies have been carried out at the community level. Colonization of the mother with ESBL-E is generally considered to be a major route of acquisition. The carrying of ESBL-E by other family members and other potential sources of transmission (food, objects and surfaces in contact with the newborn) have never been documented.

In addition, with a view to offering an intervention adapted to the local context, the local cultural determinants which govern the interactions of the newborn with his environment are important to understand.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a single-center prospective cohort of all members living in the same household in which a newborn baby has just been born.

The study consists to:

* recruit a cohort of all members of 60 households in which a newborn has just been born
* carry out semi-structured interviews and direct participant observation.

This study is divided in two parts :

* the epidemiological part : the documentation of colonization by E-ESBL by sampling the stools of the newborn, of all members of the household, and sampling of food given to the child, from surfaces in contact with it.
* the anthropological part : Semi-structured interviews with key people in the structuring of the social and family environment of the newborn and participant direct observation of households.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Enterobacteriaceae Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. For the epidemiological study :

All members of 60 households in which a newborn baby has just been born


\_ having a monofetal pregnancy
* residing regularly in the study area OR planning to reside in the study area during the study period;
* having been informed of the research and collection of biological samples on herself and her newborn;
* having given its agreement to carry out the research and the associated collection of biological samples, and;
* having signed the informed consent (or its witness if applicable).

* living after childbirth;
* whose parents or legal representatives present:
* reside regularly in the study area or plan to reside in the study area during the study period;
* were informed of the research and the associated collection of biological samples on their newborn;
* have given their agreement to carry out the research and the associated collection of biological samples,

* from the same household as the mother-child (ren) couple included
* Residing at least 4 nights per week in this home
* Having given its agreement to carry out the research and the associated collection of biological samples,
* and having signed the consent of the study (or its witness, or its legal representative if applicable)
2. for the anthropological study with interviews : 16 homes will be selected from among the 60 homes included: 8 homes in which the child has not acquired an ESBL-E during the entire follow-up and 8 homes in which the child has acquired an ESBL-E at least once during its follow-up. Among these households, interviews will be carried out with: 16 mothers or first responsible for the child in the absence of the mother 4 people with a mothering role on the child (grandmother, aunts ...) 4 minors in the families to observe 4 fathers or father figures in families to observe

Also, interviews will be done with:

Health actors: medical (1 midwife and 1 neighborhood doctor) and traditional (1 matron and 1 traditional practitioner from the neighborhood), 1 community health worker 1 neighborhood chief

* people responding to the structuring functions of the child's social and family environment
* Having given its agreement to carry out the research,
* and having signed the consent of the study (or its witness, or its legal representative if applicable)

* people responding to the targeted functions
* working in the district of homes included
* Having given its agreement to carry out the research,
* and having signed the consent of the study (or its witness, or its legal representative if applicable)

* Residents of the same household as the mother-child (ren) couple included
* having agreed to participate in the study
* Having given its agreement to carry out the research,
* and having signed the consent of the study (or its witness, or its legal representative if applicable)

Exclusion Criteria

1. For the epidemiological part:

* Pregnant woman: non-monofetal pregnancy
* Newborn: died during childbirth
* Household resident: None
2. and 3) For the anthropological part: • Semi-structured interview:

For household members:

* not responding to the structural family and social functions of the child's environment For health workers and district managers
* people not meeting the targeted functions
* not practicing in the district of homes included

• Participant direct observation:
* Not living in the same household as the mother-child couple included
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Pasteur de Madagascar

OTHER

Sponsor Role collaborator

Centre hospitalier de référence du District de Moramanga

UNKNOWN

Sponsor Role collaborator

Institut Pasteur

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bich-Tram Huynh

Role: STUDY_DIRECTOR

Institut Pasteur

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut Pasteur de Madagascar

Antananarivo, , Madagascar

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Madagascar

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bich-Tram Huynh, MD

Role: CONTACT

+33 1 45 68 83 01

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Aina HARIMANANA, MD

Role: primary

Aina Rakotondrasoa, PhD

Role: backup

+261 34 98 185 32

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-059

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.